Chartier Kirk 4
4 · Enova International, Inc. · Filed Feb 13, 2026
Research Summary
AI-generated summary of this filing
Enova (ENVA) Chief Strategy Officer Chartier Kirk Receives Awards
What Happened
- Chartier Kirk, Chief Strategy Officer of Enova International (ENVA), received equity awards on February 11, 2026. The filing shows: 4,573 restricted stock units (RSUs) granted at $0.00 and 2,938 derivative awards (a limited stock appreciation right (SAR) paired with an employee stock option) also reported at $0.00. Total cash paid for these grants was $0. These are grants/awards (not open-market purchases or sales).
Key Details
- Transaction date: 2026-02-11; Form 4 filed 2026-02-13 (filed timely).
- RSUs: 4,573 shares, $0.00 per share; vesting: roughly equal one-fourth installments on Feb 11 of 2027, 2028, 2029 and 2030 (footnote F1).
- SAR/Option package: 2,938 units, $0.00 per share (derivative). The SAR and option were granted in tandem—exercising one cancels the other (F2). Options vest in equal one-third installments on Feb 11 of 2027, 2028 and 2029 (F4). The SAR can only be exercised after a Change in Control and only for a limited post‑change window; payout equals the excess of the Offer Value Per Share over the option exercise price times the number of shares, and is payable only if an Offer occurs (F2–F3).
- Shares owned after transaction: not specified in the excerpt of the filing provided.
- Transaction code: A = Award/Grant; second line is a derivative award (SAR/option).
Context
- These awards are standard long-term compensation intended for retention (time‑based vesting). The SAR is a contingent derivative that only yields value in connection with certain change‑of‑control transactions—so it does not represent immediately tradable stock.
- Grants like these are routine and do not necessarily indicate the insider is buying or selling shares for market sentiment.
Insider Transaction Report
Form 4
Chartier Kirk
Chief Strategy Officer
Transactions
- Award
Common stock, par value $0.00001 per share
[F1]2026-02-11+4,573→ 104,972 total - Award
Non-Qualified Stock Option (right to buy) with limited SAR
[F2][F3][F4]2026-02-11+2,938→ 2,938 totalExercise: $157.79Exp: 2033-02-11→ Common stock; par value $0.00001 per share (2,938 underlying)
Footnotes (4)
- [F1]This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 11, 2027, February 11, 2028, February 11, 2029 and February 11, 2030.
- [F2]The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
- [F3]The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
- [F4]The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 11, 2027, February 11, 2028 and February 11, 2029.
Signature
/s/ Sean Rahilly, as attorney in fact|2026-02-13